Literature DB >> 21723747

Advanced glycation end products in diabetic cardiomyopathy: an alternative hypothesis.

Marion A Hofmann Bowman1, Savitri Fedson, Ann Marie Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21723747      PMCID： PMC3652259          DOI： 10.1016/j.healun.2011.06.004

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  4 in total

1.  Plasma myeloperoxidase and vitamin E levels in head injury: preliminary results related to outcome.

Authors:  P Hans; C Franssen; J Pincemail; Y Bertrand; G Hannique; P Damas; M Lamy
Journal:  J Neurosurg Anesthesiol       Date:  1992-01       Impact factor: 3.956

2.  Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes.

Authors:  Chiara Cuccurullo; Annalisa Iezzi; Maria Luigia Fazia; Domenico De Cesare; Andrea Di Francesco; Raffaella Muraro; Roberto Bei; Sante Ucchino; Francesco Spigonardo; Francesco Chiarelli; Ann Marie Schmidt; Franco Cuccurullo; Andrea Mezzetti; Francesco Cipollone
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-10-12       Impact factor: 8.311

3.  Advanced glycation end-products in myocardium-supported vessels: effects of heart failure and diabetes mellitus.

Authors:  Jerzy Nożyński; Michał Zakliczyński; Dominika Konecka-Mrówka; Roman Przybylski; Marian Zembala; Teresa Zielińska; Andrzej Mrówka; Dariusz Lange; Ewa Zembala-Nożyńska; Barbara Nikiel; Joanna Młynarczyk-Liszka
Journal:  J Heart Lung Transplant       Date:  2011-01-06       Impact factor: 10.247

4.  Production of N(epsilon)-(carboxymethyl)lysine is impaired in mice deficient in NADPH oxidase: a role for phagocyte-derived oxidants in the formation of advanced glycation end products during inflammation.

Authors:  Melissa M Anderson; Jay W Heinecke
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461
  4 in total
  1 in total

1.  Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy.

Authors:  Yanli Zhao; Lina Zhang; Yu Qiao; Xiaoling Zhou; Guodong Wu; Lujing Wang; Yahui Peng; Xingli Dong; Hui Huang; Lining Si; Xueying Zhang; Lei Zhang; Jihong Li; Wei Wang; Lingyun Zhou; Xu Gao
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.